ArticleAsia Pacific journal of clinical nutrition2026
Systemic inflammatory markers as a supplement to nutrition risk screening of ICU patients.
Article in Asia Pacific journal of clinical nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
BACKGROUND AND
objectivesCritical illness often leads to life-threatening organ dysfunction requiring intensive care. This catabolic condition significantly affects nutrition, causing muscle loss, weakness, and an in-creased risk of malnutrition, which complicates recovery. Traditional nutritional assessment tools often face limitations in critically ill patients. Systemic inflammation may improve the accuracy of nutritional risk screening. METHODS AND STUDY
designData from the MIMIC-IV database were analyzed. The study aimed to assess the prognostic value of inflammatory markers combined with the mNUTRIC score. Survival analyses were conducted using Kaplan-Meier curves and Cox regression models to evaluate the association between these markers and patient mortality at 30-day, 60-day, and 90-day intervals.
resultsA total of 2,628 ICU patients were included. High C-reactive protein (CRP; cut-off value 75.2 mg/L) had a hazard ratio (HR) of 1.345 (Log-rank p = 0.004), high neutrophil-to-lymphocyte ratio (NLR; cut-off value 8.16) had an HR of 1.266 (Log-rank p = 0.021), and albumin (cut-off value 35 g/L) was associated with an HR of 0.576 (Log-rank p < 0.001). For 60-day and 90-day mortality, similar trends were observed, with significant p-values.
conclusionsCombining inflammatory markers such as CRP, NLR, and albumin with the mNUTRIC score enhances mortality prediction in critically ill patients, improving clinical decision-making. Further research with larger, multicenter cohorts is needed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.